April 23, 2012 / 14:58 IST
Swiss food group Nestle said on Monday it would buy US drugmaker Pfizer's infant nutrition business for USD 11.85 billion, beating out French rival Danoneas both sought to gain preeminence in the lucrative baby food market.
"Its strong brands and product portfolio, its talented people dedicated to the success of its business, together with its geographic presence - 85% of its sales are in emerging markets - will complement our existing infant nutrition business perfectly," Nestle Chief Executive Paul Bulcke said.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!